Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?

Anti-cancer drugs - 1 Mar 2018

Drpa Gordana, Sreter Katherina B, Manojlovic Spomenka, Kukulj Suzana

Abstract excerpt

Adenocarcinoma (AC) is the most common type of primary pulmonary malignancy. Lung carcinoid, however, is a rare neuroendocrine tumor. Their coexistence is extremely uncommon. We report the unique case of synchronous advanced lung AC of the right upper lobe (stage IIIB) and typical endobronchial carcinoid tumor in the contralateral lower lobe in a 49-year-old white female who had never smoked. PET-computed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents

Share to Carcinoid Tumor

Share to ErbB Receptors

Share to Erlotinib Hydrochloride

Share to Neoplasms, Multiple Primary

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 29280916
DOI: 10.1097/CAD.0000000000000587

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?PMID 29280916Read ↗

KRAS-Driven Combined Pulmonary Adenocarcinoma and Atypical Carcinoid Tumor: A Rare Case with Shared Clonal Origins.Semantic proximity Read ↗

Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer.Semantic proximity Read ↗

Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.Semantic proximity Read ↗

BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.Semantic proximity Read ↗

Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases.Semantic proximity Read ↗

Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.Semantic proximity Read ↗

Synchronous primary lung cancer and epidermal growth factor receptor mutation.Semantic proximity Read ↗

Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal originSemantic proximity Read ↗

A case of a primary lung cancer comprised of adenocarcinoma and atypical carcinoid tumor with both components harboring BRAF p.V600E mutation.Semantic proximity Read ↗

BRAF V600E-mutated combined large cell neuroendocrine carcinoma and adenocarcinoma responding to targeted therapy.Semantic proximity Read ↗

Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.Semantic proximity Read ↗

[Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes: A Case Report and Literature Review].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.